{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:44:26Z","timestamp":1791092666318,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["GJHZ20190820115203714"],"award-info":[{"award-number":["GJHZ20190820115203714"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JSGG20191129094218565"],"award-info":[{"award-number":["JSGG20191129094218565"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Osteoarthritis (OA) is a chronic degenerative\u00a0joint disease characterized\u00a0by the destruction of the articular cartilage, sclerosis\u00a0of the subchondral bone, and joint dysfunction. Its pathogenesis is attributed to direct damage and mechanical destruction of joint tissues. Mesenchymal stem cells (MSCs), suggested as a potential strategy for the treatment of OA, have shown therapeutic effects on OA. However, the specific fate of MSCs after intraarticular injection,\u00a0including\u00a0cell\u00a0attachment,\u00a0proliferation,\u00a0differentiation, and death, is still unclear, and there is no guarantee that stem cells can be retained in the cartilage tissue to enact repair. Direct homing of MSCs is an important determinant of the efficacy of MSC-based cartilage repair. Recent studies have revealed that the unique homing capacity of MSCs and targeted modification can improve their ability to promote tissue regeneration. Here, we comprehensively review the homing effect of stem cells in joints and highlight progress toward the targeted modification of MSCs. In the future, developments of this targeting system that accelerate tissue regeneration will benefit targeted tissue repair.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12967-022-03726-8","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T17:03:01Z","timestamp":1667926981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Modification of mesenchymal stem cells for cartilage-targeted therapy"],"prefix":"10.1186","volume":"20","author":[{"given":"Jianghong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qisong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0860-4859","authenticated-orcid":false,"given":"Yujie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"3726_CR1","first-page":"S245","volume":"7","author":"M DeRogatis","year":"2019","unstructured":"DeRogatis M, Anis HK, Sodhi N, Ehiorobo JO, Chughtai M, Bhave A, Mont MA. Non-operative treatment options for knee osteoarthritis. AnnTranslat Med. 2019;7:S245\u2013S245.","journal-title":"AnnTranslat Med"},{"key":"3726_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s13287-021-02609-x","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yi H, Song Y. The safety of MSC therapy over the past 15 years: a meta-analysis. Stem Cell Res Ther. 2021;12:545.","journal-title":"Stem Cell Res Ther"},{"key":"3726_CR3","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.jcyt.2018.08.005","volume":"20","author":"M Emadedin","year":"2018","unstructured":"Emadedin M, Labibzadeh N, Liastani MG, Karimi A, Jaroughi N, Bolurieh T, Hosseini S-E, Baharvand H, Aghdami N. Intra-articular implantation of autologous bone marrow\u2013derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1\/2 clinical trial. Cytotherapy. 2018;20:1238\u201346.","journal-title":"Cytotherapy"},{"key":"3726_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2106\/JBJS.M.00058","volume":"96","author":"CT Vangsness Jr","year":"2014","unstructured":"Vangsness CT Jr, Farr J 2nd, Boyd J, Dellaero DT, Mills CR, LeRoux-Williams M. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am. 2014;96:90\u20138.","journal-title":"J Bone Joint Surg Am"},{"key":"3726_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0929-6646(09)60039-5","volume":"108","author":"H Chiang","year":"2009","unstructured":"Chiang H, Jiang C-C. Repair of articular cartilage defects: review and perspectives. J Formos Med Assoc. 2009;108:87\u2013101.","journal-title":"J Formos Med Assoc"},{"key":"3726_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrrheum.2014.200","volume":"11","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Tuan RS. Origin and function of cartilage stem\/progenitor cells in osteoarthritis. Nat Rev Rheumatol. 2015;11:206\u201312.","journal-title":"Nat Rev Rheumatol"},{"key":"3726_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/scrt501","volume":"5","author":"EB de Sousa","year":"2014","unstructured":"de Sousa EB, Casado PL, Moura Neto V, Duarte MEL, Aguiar DP. Synovial fluid and synovial membrane mesenchymal stem cells: latest discoveries and therapeutic perspectives. Stem Cell Res Ther. 2014;5:112\u2013112.","journal-title":"Stem Cell Res Ther"},{"key":"3726_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/597652","volume":"2015","author":"F Perdisa","year":"2015","unstructured":"Perdisa F, Gosty\u0144ska N, Roffi A, Filardo G, Marcacci M, Kon E. Adipose-derived mesenchymal stem cells for the treatment of articular cartilage: a systematic review on preclinical and clinical evidence. Stem Cells International. 2015;2015: 597652.","journal-title":"Stem Cells International"},{"key":"3726_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1517\/14712598.2016.1145651","volume":"16","author":"D Reissis","year":"2016","unstructured":"Reissis D, Tang QO, Cooper NC, Carasco CF, Gamie Z, Mantalaris A, Tsiridis E. Current clinical evidence for the use of mesenchymal stem cells in articular cartilage repair. Expert Opin Biol Ther. 2016;16:535\u201357.","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"3726_CR10","first-page":"343","volume":"11","author":"CJ Centeno","year":"2008","unstructured":"Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Phys 2008;11(3):343\u201353.","journal-title":"Pain Phys"},{"key":"3726_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/1947603510366027","volume":"1","author":"AM Haleem","year":"2010","unstructured":"Haleem AM, Singergy AAE, Sabry D, Atta HM, Rashed LA, Chu CR, El Shewy MT, Azzam A, Abdel Aziz MT. The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage. 2010;1:253\u201361.","journal-title":"Cartilage"},{"key":"3726_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.joca.2006.08.008","volume":"15","author":"R Kuroda","year":"2007","unstructured":"Kuroda R, Ishida K, Matsumoto T, Akisue T, Fujioka H, Mizuno K, Ohgushi H, Wakitani S, Kurosaka M. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage. 2007;15:226\u201331.","journal-title":"Osteoarthritis Cartilage"},{"key":"3726_CR13","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1177\/0363546514529641","volume":"42","author":"YG Koh","year":"2014","unstructured":"Koh YG, Choi YJ, Kwon OR, Kim YS. Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees. Am J Sports Med. 2014;42:1628\u201337.","journal-title":"Am J Sports Med"},{"key":"3726_CR14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jbspin.2007.09.013","volume":"75","author":"XH Jing","year":"2008","unstructured":"Jing XH, Yang L, Duan XJ, Xie B, Chen W, Li Z, Tan HB. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine. 2008;75:432\u20138.","journal-title":"Joint Bone Spine"},{"key":"3726_CR15","first-page":"343","volume":"11","author":"CJ Centeno","year":"2008","unstructured":"Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008;11:343\u201353.","journal-title":"Pain Physician"},{"key":"3726_CR16","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/TP.0b013e318291a2da","volume":"95","author":"L Orozco","year":"2013","unstructured":"Orozco L, Munar A, Soler R, Alberca M, Soler F, Huguet M, Sent\u00eds J, S\u00e1nchez A, Garc\u00eda-Sancho J. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation. 2013;95:1535\u201341.","journal-title":"Transplantation"},{"key":"3726_CR17","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/sctm.18-0183","volume":"8","author":"J Chahal","year":"2019","unstructured":"Chahal J, G\u00f3mez-Aristiz\u00e1bal A, Shestopaloff K, Bhatt S, Chaboureau A, Fazio A, Chisholm J, Weston A, Chiovitti J, Keating A, et al. Bone marrow mesenchymal stromal cell treatment in patients with osteoarthritis results in overall improvement in pain and symptoms and reduces synovial inflammation. Stem Cells Transl Med. 2019;8:746\u201357.","journal-title":"Stem Cells Transl Med"},{"key":"3726_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1756-185X.2011.01599.x","volume":"14","author":"F Davatchi","year":"2011","unstructured":"Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis preliminary report of four patients. Int J Rheum Dis. 2011;14:211\u20135.","journal-title":"Int J Rheum Dis"},{"key":"3726_CR19","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.jcyt.2018.08.005","volume":"20","author":"M Emadedin","year":"2018","unstructured":"Emadedin M, Labibzadeh N, Liastani MG, Karimi A, Jaroughi N, Bolurieh T, Hosseini SE, Baharvand H, Aghdami N. Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1\/2 clinical trial. Cytotherapy. 2018;20:1238\u201346.","journal-title":"Cytotherapy"},{"key":"3726_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13018-017-0689-6","volume":"12","author":"M Al-Najar","year":"2017","unstructured":"Al-Najar M, Khalil H, Al-Ajlouni J, Al-Antary E, Hamdan M, Rahmeh R, Alhattab D, Samara O, Yasin M, Abdullah AA, et al. Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I\/II study. J Orthop Surg Res. 2017;12:190.","journal-title":"J Orthop Surg Res"},{"key":"3726_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12967-016-0998-2","volume":"14","author":"JM Lamo-Espinosa","year":"2016","unstructured":"Lamo-Espinosa JM, Mora G, Blanco JF, Granero-Molt\u00f3 F, Nu\u00f1ez-C\u00f3rdoba JM, S\u00e1nchez-Echenique C, Bond\u00eda JM, Aquerreta JD, Andreu EJ, Ornilla E, et al. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I\/II). J Transl Med. 2016;14:246.","journal-title":"J Transl Med"},{"key":"3726_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12967-018-1591-7","volume":"16","author":"JM Lamo-Espinosa","year":"2018","unstructured":"Lamo-Espinosa JM, Mora G, Blanco JF, Granero-Molt\u00f3 F, N\u00fa\u00f1ez-C\u00f3rdoba JM, L\u00f3pez-El\u00edo S, Andreu E, S\u00e1nchez-Guijo F, Aquerreta JD, Bond\u00eda JM, et al. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I\/II). J Transl Med. 2018;16:213.","journal-title":"J Transl Med"},{"key":"3726_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/1756-185X.12670","volume":"19","author":"F Davatchi","year":"2016","unstructured":"Davatchi F, Sadeghi Abdollahi B, Mohyeddin M, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients. Int J Rheum Dis. 2016;19:219\u201325.","journal-title":"Int J Rheum Dis"},{"key":"3726_CR24","first-page":"336","volume":"18","author":"M Emadedin","year":"2015","unstructured":"Emadedin M, Ghorbani Liastani M, Fazeli R, Mohseni F, Moghadasali R, Mardpour S, Hosseini SE, Niknejadi M, Moeininia F, Aghahossein Fanni A, et al. Long-term follow-up of intra-articular injection of autologous mesenchymal stem cells in patients with knee, ankle, or hip osteoarthritis. Arch Iran Med. 2015;18:336\u201344.","journal-title":"Arch Iran Med"},{"key":"3726_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/stem.2475","volume":"35","author":"TS de Windt","year":"2017","unstructured":"de Windt TS, Vonk LA, Slaper-Cortenbach IC, van den Broek MP, Nizak R, van Rijen MH, de Weger RA, Dhert WJ, Saris DB. Allogeneic mesenchymal stem cells stimulate cartilage regeneration and are safe for single-stage cartilage repair in humans upon mixture with recycled autologous chondrons. Stem Cells. 2017;35:256\u201364.","journal-title":"Stem Cells"},{"key":"3726_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13075-016-1195-7","volume":"18","author":"PK Gupta","year":"2016","unstructured":"Gupta PK, Chullikana A, Rengasamy M, Shetty N, Pandey V, Agarwal V, Wagh SY, Vellotare PK, Damodaran D, Viswanathan P, et al. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel\u00ae): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Ther. 2016;18:301.","journal-title":"Arthritis Res Ther"},{"key":"3726_CR27","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1097\/TP.0000000000000678","volume":"99","author":"A Vega","year":"2015","unstructured":"Vega A, Mart\u00edn-Ferrero MA, Del Canto F, Alberca M, Garc\u00eda V, Munar A, Orozco L, Soler R, Fuertes JJ, Huguet M, et al. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015;99:1681\u201390.","journal-title":"Transplantation"},{"key":"3726_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2217\/rme-2017-0152","volume":"13","author":"Y Song","year":"2018","unstructured":"Song Y, Du H, Dai C, Zhang L, Li S, Hunter DJ, Lu L, Bao C. Human adipose-derived mesenchymal stem cells for osteoarthritis: a pilot study with long-term follow-up and repeated injections. Regen Med. 2018;13:295\u2013307.","journal-title":"Regen Med"},{"key":"3726_CR29","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1177\/0363546515599632","volume":"43","author":"YS Kim","year":"2015","unstructured":"Kim YS, Kwon OR, Choi YJ, Suh DS, Heo DB, Koh YG. Comparative matched-pair analysis of the injection versus implantation of mesenchymal stem cells for knee osteoarthritis. Am J Sports Med. 2015;43:2738\u201346.","journal-title":"Am J Sports Med"},{"key":"3726_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.joca.2015.08.009","volume":"24","author":"YS Kim","year":"2016","unstructured":"Kim YS, Choi YJ, Lee SW, Kwon OR, Suh DS, Heo DB, Koh YG. Assessment of clinical and MRI outcomes after mesenchymal stem cell implantation in patients with knee osteoarthritis: a prospective study. Osteoarthr Cartilage. 2016;24:237\u201345.","journal-title":"Osteoarthr Cartilage"},{"key":"3726_CR31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.5966\/sctm.2015-0245","volume":"5","author":"YM Pers","year":"2016","unstructured":"Pers YM, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, Sensebe L, Casteilla L, Fleury S, Bourin P, et al. Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial. Stem Cells Transl Med. 2016;5:847\u201356.","journal-title":"Stem Cells Transl Med"},{"key":"3726_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/asj\/sjv135","volume":"36","author":"PB Fodor","year":"2016","unstructured":"Fodor PB, Paulseth SG. Adipose derived stromal cell (ADSC) injections for pain management of osteoarthritis in the human knee joint. Aesthet Surg J. 2016;36:229\u201336.","journal-title":"Aesthet Surg J"},{"key":"3726_CR33","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/stem.1634","volume":"32","author":"CH Jo","year":"2014","unstructured":"Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, Kim JE, Shim H, Shin JS, Shin IS, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 2014;32:1254\u201366.","journal-title":"Stem Cells"},{"issue":"6","key":"3726_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2217\/rme-2022-0002","volume":"17","author":"J Freitag","year":"2022","unstructured":"Freitag J, Wickham J, Shah K, Tenen A. Real-world evidence of mesenchymal stem cell therapy in knee osteoarthritis: a large prospective two-year case series. Regen Med. 2022;17(6):355\u201373.","journal-title":"Regen Med"},{"key":"3726_CR35","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1016\/j.arthro.2021.02.022","volume":"37","author":"NH Lee","year":"2021","unstructured":"Lee NH, Na SM, Ahn HW, Kang JK, Seon JK, Song EK. Allogenic human umbilical cord blood-derived mesenchymal stem cells are more effective than bone marrow aspiration concentrate for cartilage regeneration after high tibial osteotomy in medial unicompartmental osteoarthritis of knee. Arthroscopy. 2021;37:2521\u201330.","journal-title":"Arthroscopy"},{"key":"3726_CR36","doi-asserted-by":"publisher","first-page":"232596712097305","DOI":"10.1177\/2325967120973052","volume":"9","author":"H-C Lim","year":"2021","unstructured":"Lim H-C, Park Y-B, Ha C-W, Cole BJ, Lee B-K, Jeong H-J, Kim M-K, Bin S-I, Choi C-H, Choi CH, et al. Allogeneic umbilical cord blood-derived mesenchymal stem cell implantation versus microfracture for large, full-thickness cartilage defects in older patients: a multicenter randomized clinical trial and extended 5-year clinical follow-up. Orthop J Sports Med. 2021;9:2325967120973052.","journal-title":"Orthop J Sports Med"},{"key":"3726_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/sctm.18-0053","volume":"8","author":"J Matas","year":"2019","unstructured":"Matas J, Orrego M, Amenabar D, Infante C, Tapia-Limonchi R, Cadiz MI, Alcayaga-Miranda F, Gonz\u00e1lez PL, Muse E, Khoury M, et al. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I\/II trial. Stem Cells Transl Med. 2019;8:215\u201324.","journal-title":"Stem Cells Transl Med"},{"key":"3726_CR38","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00590-020-02630-5","volume":"30","author":"IH Dilogo","year":"2020","unstructured":"Dilogo IH, Canintika AF, Hanitya AL, Pawitan JA, Liem IK, Pandelaki J. Umbilical cord-derived mesenchymal stem cells for treating osteoarthritis of the knee: a single-arm, open-label study. Eur J Orthop Surg Traumatol. 2020;30:799\u2013807.","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"3726_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.5966\/sctm.2016-0157","volume":"6","author":"Y-B Park","year":"2017","unstructured":"Park Y-B, Ha C-W, Lee C-H, Yoon YC, Park Y-G. Cartilage regeneration in osteoarthritic patients by a composite of allogeneic umbilical cord blood-derived mesenchymal stem cells and hyaluronate hydrogel: results from a clinical trial for safety and proof-of-concept with 7 years of extended follow-up. Stem Cells Transl Med. 2017;6:613\u201321.","journal-title":"Stem Cells Transl Med"},{"key":"3726_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.reth.2019.10.003","volume":"14","author":"J-S Song","year":"2020","unstructured":"Song J-S, Hong K-T, Kim N-M, Jung J-Y, Park H-S, Lee SH, Cho YJ, Kim SJ. Implantation of allogenic umbilical cord blood-derived mesenchymal stem cells improves knee osteoarthritis outcomes: Two-year follow-up. Regenerative therapy. 2020;14:32\u20139.","journal-title":"Regenerative therapy"},{"key":"3726_CR41","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.knee.2012.04.001","volume":"19","author":"YG Koh","year":"2012","unstructured":"Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19:902\u20137.","journal-title":"Knee"},{"key":"3726_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/5584_2017_9","volume":"1020","author":"B Sadlik","year":"2017","unstructured":"Sadlik B, Jaroslawski G, Gladysz D, Puszkarz M, Markowska M, Pawelec K, Boruczkowski D, Oldak T. Knee cartilage regeneration with umbilical cord mesenchymal stem cells embedded in collagen scaffold using dry arthroscopy technique. Adv Exp Med Biol. 2017;1020:113\u201322.","journal-title":"Adv Exp Med Biol"},{"key":"3726_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcyt.2018.11.003","volume":"21","author":"S Khalifeh Soltani","year":"2019","unstructured":"Khalifeh Soltani S, Forogh B, Ahmadbeigi N, Hadizadeh Kharazi H, Fallahzadeh K, Kashani L, Karami M, Kheyrollah Y, Vasei M. Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study. Cytotherapy. 2019;21:54\u201363.","journal-title":"Cytotherapy"},{"key":"3726_CR44","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1007\/s11999-015-4324-8","volume":"473","author":"I Sekiya","year":"2015","unstructured":"Sekiya I, Muneta T, Horie M, Koga H. Arthroscopic transplantation of synovial stem cells improves clinical outcomes in knees with cartilage defects. Clin Orthop Relat Res. 2015;473:2316\u201326.","journal-title":"Clin Orthop Relat Res"},{"key":"3726_CR45","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/jgm.452","volume":"5","author":"A Chapel","year":"2003","unstructured":"Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J, Demarquay C, Cuvelier F, Mathieu E, Trompier F, et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med. 2003;5:1028\u201338.","journal-title":"J Gene Med"},{"key":"3726_CR46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri3209","volume":"12","author":"K Le Blanc","year":"2012","unstructured":"Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12:383\u201396.","journal-title":"Nat Rev Immunol"},{"key":"3726_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pharmthera.2014.02.013","volume":"143","author":"A Bronckaers","year":"2014","unstructured":"Bronckaers A, Hilkens P, Martens W, Gervois P, Ratajczak J, Struys T, Lambrichts I. Mesenchymal stem\/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol Ther. 2014;143:181\u201396.","journal-title":"Pharmacol Ther"},{"key":"3726_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.isci.2019.05.004","volume":"15","author":"M Ullah","year":"2019","unstructured":"Ullah M, Liu DD, Thakor AS. Mesenchymal stromal cell homing: mechanisms and strategies for improvement. iScience. 2019;15:421\u201338.","journal-title":"iScience"},{"key":"3726_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jcb.21172","volume":"101","author":"J Ringe","year":"2007","unstructured":"Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR, Kaps C, Sittinger M. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem. 2007;101:135\u201346.","journal-title":"J Cell Biochem"},{"key":"3726_CR50","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1634\/stemcells.2007-0054","volume":"25","author":"AL Ponte","year":"2007","unstructured":"Ponte AL, Marais E, Gallay N, Langonn\u00e9 A, Delorme B, H\u00e9rault O, Charbord P, Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007;25:1737\u201345.","journal-title":"Stem Cells"},{"key":"3726_CR51","doi-asserted-by":"publisher","first-page":"10816","DOI":"10.1111\/jcmm.15706","volume":"24","author":"X Xiang","year":"2020","unstructured":"Xiang X, Liu H, Wang L, Zhu B, Ma L, Du F, Li L, Qiu L. Ultrasound combined with SDF-1\u03b1 chemotactic microbubbles promotes stem cell homing in an osteoarthritis model. J Cell Mol Med. 2020;24:10816\u201329.","journal-title":"J Cell Mol Med"},{"key":"3726_CR52","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1089\/ten.tea.2011.0380","volume":"18","author":"A Sukegawa","year":"2012","unstructured":"Sukegawa A, Iwasaki N, Kasahara Y, Onodera T, Igarashi T, Minami A. Repair of rabbit osteochondral defects by an acellular technique with an ultrapurified alginate gel containing stromal cell-derived factor-1. Tissue Eng Part A. 2012;18:934\u201345.","journal-title":"Tissue Eng Part A"},{"key":"3726_CR53","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1089\/ten.tea.2012.0441","volume":"19","author":"F Zhang","year":"2013","unstructured":"Zhang F, Leong W, Su K, Fang Y, Wang DA. A transduced living hyaline cartilage graft releasing transgenic stromal cell-derived factor-1 inducing endogenous stem cell homing in vivo. Tissue Eng Part A. 2013;19:1091\u20139.","journal-title":"Tissue Eng Part A"},{"key":"3726_CR54","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/rheumatology\/keu377","volume":"54","author":"OI Eseonu","year":"2014","unstructured":"Eseonu OI, De Bari C. Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis. Rheumatology. 2014;54:210\u20138.","journal-title":"Rheumatology"},{"key":"3726_CR55","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3324\/haematol.10669","volume":"92","author":"M Shi","year":"2007","unstructured":"Shi M, Li J, Liao L, Chen B, Li B, Chen L, Jia H, Zhao RC. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD\/SCID mice. Haematologica. 2007;92:897\u2013904.","journal-title":"Haematologica"},{"key":"3726_CR56","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fbioe.2020.00641","volume":"8","author":"SB Goodman","year":"2020","unstructured":"Goodman SB, Lin T. Modifying MSC phenotype to facilitate bone healing: biological approaches. Front Bioeng Biotechnol. 2020;8:641\u2013641.","journal-title":"Front Bioeng Biotechnol"},{"key":"3726_CR57","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.bbrc.2007.03.049","volume":"356","author":"Y Li","year":"2007","unstructured":"Li Y, Yu X, Lin S, Li X, Zhang S, Song YH. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun. 2007;356:780\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"3726_CR58","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1161\/STROKEAHA.110.612788","volume":"42","author":"LK Tsai","year":"2011","unstructured":"Tsai LK, Wang Z, Munasinghe J, Leng Y, Leeds P, Chuang DM. Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model. Stroke. 2011;42:2932\u20139.","journal-title":"Stroke"},{"key":"3726_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.100898","volume":"34","author":"A Vedadghavami","year":"2020","unstructured":"Vedadghavami A, Zhang C, Bajpayee AG. Overcoming negatively charged tissue barriers: drug delivery using cationic peptides and proteins. Nano Today. 2020;34: 100898.","journal-title":"Nano Today"},{"key":"3726_CR60","doi-asserted-by":"publisher","first-page":"4956063","DOI":"10.1155\/2016\/4956063","volume":"2016","author":"A Nowakowski","year":"2016","unstructured":"Nowakowski A, Walczak P, Lukomska B, Janowski M. Genetic engineering of mesenchymal stem cells to induce their migration and survival. Stem Cells Int. 2016;2016:4956063.","journal-title":"Stem Cells Int"},{"key":"3726_CR61","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/mt.2009.153","volume":"17","author":"SW Cho","year":"2009","unstructured":"Cho SW, Sun HJ, Yang JY, Jung JY, An JH, Cho HY, Choi HJ, Kim SW, Kim SY, Kim D, Shin CS. Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Mol Ther. 2009;17:1979\u201387.","journal-title":"Mol Ther"},{"key":"3726_CR62","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/sj.mt.6300374","volume":"16","author":"Z Cheng","year":"2008","unstructured":"Cheng Z, Ou L, Zhou X, Li F, Jia X, Zhang Y, Liu X, Li Y, Ward CA, Melo LG, Kong D. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther. 2008;16:571\u20139.","journal-title":"Mol Ther"},{"key":"3726_CR63","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jcyt.2013.02.009","volume":"15","author":"LA Marquez-Curtis","year":"2013","unstructured":"Marquez-Curtis LA, Gul-Uludag H, Xu P, Chen J, Janowska-Wieczorek A. CXCR4 transfection of cord blood mesenchymal stromal cells with the use of cationic liposome enhances their migration toward stromal cell-derived factor-1. Cytotherapy. 2013;15:840\u20139.","journal-title":"Cytotherapy"},{"key":"3726_CR64","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/biomedicines9080880","volume":"9","author":"SB Sulaiman","year":"2021","unstructured":"Sulaiman SB, Chowdhury SR, Busra MFBM, Abdul Rani RB, Mohamad Yahaya NHB, Tabata Y, Hiraoka Y, Haji Idrus RB, Hwei NM. Type II collagen-conjugated mesenchymal stem cells micromass for articular tissue targeting. Biomedicines. 2021;9:880.","journal-title":"Biomedicines"},{"key":"3726_CR65","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1016\/j.biomaterials.2009.03.038","volume":"30","author":"IK Ko","year":"2009","unstructured":"Ko IK, Kean TJ, Dennis JE. Targeting mesenchymal stem cells to activated endothelial cells. Biomaterials. 2009;30:3702\u201310.","journal-title":"Biomaterials"},{"key":"3726_CR66","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/mt.2010.54","volume":"18","author":"IK Ko","year":"2010","unstructured":"Ko IK, Kim B-G, Awadallah A, Mikulan J, Lin P, Letterio JJ, Dennis JE. Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther. 2010;18:1365\u201372.","journal-title":"Mol Ther"},{"key":"3726_CR67","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.orthres.2003.12.002","volume":"22","author":"JE Dennis","year":"2004","unstructured":"Dennis JE, Cohen N, Goldberg VM, Caplan AI. Targeted delivery of progenitor cells for cartilage repair. J Orthop Res. 2004;22:735\u201341.","journal-title":"J Orthop Res"},{"key":"3726_CR68","doi-asserted-by":"publisher","first-page":"38715","DOI":"10.1021\/acsami.8b11687","volume":"10","author":"S Xun","year":"2018","unstructured":"Xun S. In Situ Articular Cartilage Regeneration through Endogenous Reparative Cell Homing Using a Functional Bone Marrow-Specific Scaffolding System. ACS Appl Mater Interf. 2018;10:38715\u201328.","journal-title":"ACS Appl Mater Interf"},{"key":"3726_CR69","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1016\/j.biomaterials.2011.05.017","volume":"32","author":"Y Pi","year":"2011","unstructured":"Pi Y, Zhang X, Shi J, Zhu J, Chen W, Zhang C, Gao W, Zhou C, Ao Y. Targeted delivery of non-viral vectors to cartilage in vivo using a chondrocyte-homing peptide identified by phage display. Biomaterials. 2011;32:6324\u201332.","journal-title":"Biomaterials"},{"key":"3726_CR70","doi-asserted-by":"publisher","first-page":"36938","DOI":"10.1021\/acsami.0c10458","volume":"12","author":"Y Liang","year":"2020","unstructured":"Liang Y, Xu X, Li X, Xiong J, Li B, Duan L, Wang D, Xia J. Chondrocyte-targeted MicroRNA delivery by engineered exosomes toward a cell-free osteoarthritis therapy. ACS Appl Mater Interfaces. 2020;12:36938\u201347.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3726_CR71","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11:3183\u201395.","journal-title":"Theranostics"},{"key":"3726_CR72","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/jor.22325","volume":"31","author":"CSF Cheung","year":"2013","unstructured":"Cheung CSF, Lui JC, Baron J. Identification of chondrocyte-binding peptides by phage display. J Orthopaedic Res. 2013;31:1053\u20138.","journal-title":"J Orthopaedic Res"},{"issue":"533","key":"3726_CR73","doi-asserted-by":"publisher","first-page":"eaay1041","DOI":"10.1126\/scitranslmed.aay1041","volume":"12","author":"ML Cook Sangar","year":"2020","unstructured":"Cook Sangar ML, Girard EJ, Hopping G, Yin C, Pakiam F, Brusniak MY, Nguyen E, Ruff R, Gewe MM, Byrnes-Blake K, et al. A potent peptide-steroid conjugate accumulates in cartilage and reverses arthritis without evidence of systemic corticosteroid exposure. Sci Transl Med. 2020;12(533):eaay1041.","journal-title":"Sci Transl Med"},{"key":"3726_CR74","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1126\/science.1247663","volume":"343","author":"MM Martino","year":"2014","unstructured":"Martino MM, Briquez PS, G\u00fc\u00e7 E, Tortelli F, Kilarski WW, Metzger S, Rice JJ, Kuhn GA, M\u00fcller R, Swartz MA, Hubbell JA. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science. 2014;343:885\u20138.","journal-title":"Science"},{"key":"3726_CR75","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13075-019-2075-8","volume":"21","author":"K Katsumata","year":"2019","unstructured":"Katsumata K, Ishihara J, Fukunaga K, Ishihara A, Yuba E, Budina E, Hubbell JA. Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-\u03b1 antibody in a murine model of rheumatoid arthritis. Arthritis Res Ther. 2019;21:298.","journal-title":"Arthritis Res Ther"},{"key":"3726_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120996","volume":"276","author":"R Cuahtecontzi Delint","year":"2021","unstructured":"Cuahtecontzi Delint R, Day GJ, Macalester WJP, Kafienah W, Xiao W, Perriman AW. An artificial membrane binding protein-polymer surfactant nanocomplex facilitates stem cell adhesion to the cartilage extracellular matrix. Biomaterials. 2021;276: 120996.","journal-title":"Biomaterials"},{"key":"3726_CR77","doi-asserted-by":"publisher","first-page":"2101715","DOI":"10.1002\/adhm.202101715","volume":"11","author":"E Ren","year":"2022","unstructured":"Ren E, Chen H, Qin Z, Guan S, Jiang L, Pang X, He Y, Zhang Y, Gao X, Chu C, et al. Harnessing bifunctional ferritin with kartogenin loading for mesenchymal stem cell capture and enhancing chondrogenesis in cartilage regeneration. Adv Healthcare Mater. 2022;11:2101715.","journal-title":"Adv Healthcare Mater"},{"key":"3726_CR78","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.actbio.2018.12.004","volume":"93","author":"A Vedadghavami","year":"2019","unstructured":"Vedadghavami A, Wagner EK, Mehta S, He T, Zhang C, Bajpayee AG. Cartilage penetrating cationic peptide carriers for applications in drug delivery to avascular negatively charged tissues. Acta Biomater. 2019;93:258\u201369.","journal-title":"Acta Biomater"},{"key":"3726_CR79","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.biomaterials.2018.08.050","volume":"183","author":"Y Krishnan","year":"2018","unstructured":"Krishnan Y, Rees HA, Rossitto CP, Kim S-E, Hung H-HK, Frank EH, Olsen BD, Liu DR, Hammond PT, Grodzinsky AJ. Green fluorescent proteins engineered for cartilage-targeted drug delivery: Insights for transport into highly charged avascular tissues. Biomaterials. 2018;183:218\u201333.","journal-title":"Biomaterials"},{"key":"3726_CR80","doi-asserted-by":"publisher","first-page":"eaay1971","DOI":"10.1126\/sciadv.aay1971","volume":"5","author":"K Katsumata","year":"2019","unstructured":"Katsumata K, Ishihara J, Mansurov A, Ishihara A, Raczy MM, Yuba E, Hubbell JA. Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies. Science Adv. 2019;5:eaay1971\u2013eaay1971.","journal-title":"Science Adv"},{"key":"3726_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202101715","volume":"11","author":"E Ren","year":"2022","unstructured":"Ren E, Chen H, Qin Z, Guan S, Jiang L, Pang X, He Y, Zhang Y, Gao X, Chu C, et al. Harnessing bifunctional ferritin with kartogenin loading for mesenchymal stem cell capture and enhancing chondrogenesis in cartilage regeneration. Adv Healthc Mater. 2022;11: e2101715.","journal-title":"Adv Healthc Mater"},{"key":"3726_CR82","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmat2116","volume":"7","author":"DA Rothenfluh","year":"2008","unstructured":"Rothenfluh DA, Bermudez H, O\u2019Neil CP, Hubbell JA. Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. Nat Mater. 2008;7:248\u201354.","journal-title":"Nat Mater"},{"key":"3726_CR83","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.bioactmat.2021.01.017","volume":"6","author":"S Xue","year":"2021","unstructured":"Xue S, Zhou X, Sang W, Wang C, Lu H, Xu Y, Zhong Y, Zhu L, He C, Ma J. Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy. Bioact Mater. 2021;6:2372\u201389.","journal-title":"Bioact Mater"},{"key":"3726_CR84","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/s41598-020-57586-7","volume":"10","author":"C Shortt","year":"2020","unstructured":"Shortt C, Luyt LG, Turley EA, Cowman MK, Kirsch T. A hyaluronan-binding peptide (P15\u20131) reduces inflammatory and catabolic events in il-1\u03b2-treated human articular chondrocytes. Sci Rep. 2020;10:1441.","journal-title":"Sci Rep"},{"key":"3726_CR85","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41551-021-00780-3","volume":"5","author":"SK Bedingfield","year":"2021","unstructured":"Bedingfield SK, Colazo JM, Yu F, Liu DD, Jackson MA, Himmel LE, Cho H, Crofford LJ, Hasty KA, Duvall CL. Amelioration of post-traumatic osteoarthritis via nanoparticle depots delivering small interfering RNA to damaged cartilage. Nat Biomed Eng. 2021;5:1069\u201383.","journal-title":"Nat Biomed Eng"},{"key":"3726_CR86","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jor.23756","volume":"36","author":"JT Hulme","year":"2018","unstructured":"Hulme JT, D\u2019Souza WN, McBride HJ, Yoon BP, Willee AM, Duguay A, Thomas M, Fan B, Dayao MR, Rottman JB, et al. Novel protein therapeutic joint retention strategy based on collagen-binding Avimers. J Orthop Res. 2018;36:1238\u201347.","journal-title":"J Orthop Res"},{"key":"3726_CR87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jconrel.2019.12.020","volume":"318","author":"T He","year":"2020","unstructured":"He T, Zhang C, Vedadghavami A, Mehta S, Clark HA, Porter RM, Bajpayee AG. Multi-arm Avidin nano-construct for intra-cartilage delivery of small molecule drugs. J Control Rel. 2020;318:109\u201323.","journal-title":"J Control Rel"},{"key":"3726_CR88","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.biomaterials.2013.09.091","volume":"35","author":"AG Bajpayee","year":"2014","unstructured":"Bajpayee AG, Wong CR, Bawendi MG, Frank EH, Grodzinsky AJ. Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis. Biomaterials. 2014;35:538\u201349.","journal-title":"Biomaterials"},{"key":"3726_CR89","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13287-017-0523-4","volume":"8","author":"LHA Silva","year":"2017","unstructured":"Silva LHA, Cruz FF, Morales MM, Weiss DJ, Rocco PRM. Magnetic targeting as a strategy to enhance therapeutic effects of mesenchymal stromal cells. Stem Cell Res Ther. 2017;8:58\u201358.","journal-title":"Stem Cell Res Ther"},{"key":"3726_CR90","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1021\/acsomega.8b00291","volume":"3","author":"J Huang","year":"2018","unstructured":"Huang J, Liang Y, Jia Z, Chen J, Duan L, Liu W, Zhu F, Liang Q, Zhu W, You W, et al. Development of magnetic nanocomposite hydrogel with potential cartilage tissue engineering. ACS Omega. 2018;3:6182\u20139.","journal-title":"ACS Omega"},{"key":"3726_CR91","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1021\/acsbiomaterials.9b00025","volume":"5","author":"J Huang","year":"2019","unstructured":"Huang J, Liang Y, Huang Z, Zhao P, Liang Q, Liu Y, Duan L, Liu W, Zhu F, Bian L, et al. Magnetic enhancement of chondrogenic differentiation of mesenchymal stem cells. ACS Biomater Sci Eng. 2019;5:2200\u20137.","journal-title":"ACS Biomater Sci Eng"},{"key":"3726_CR92","doi-asserted-by":"publisher","first-page":"9733","DOI":"10.1021\/acsomega.9b04080","volume":"5","author":"J Huang","year":"2020","unstructured":"Huang J, Liang Y, Huang Z, Xiong J, Wang D. Preparation, characterization, and biological testing of novel magnetic nanocomposite hydrogels. ACS Omega. 2020;5:9733\u201343.","journal-title":"ACS Omega"},{"key":"3726_CR93","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.arthro.2007.08.017","volume":"24","author":"T Kobayashi","year":"2008","unstructured":"Kobayashi T, Ochi M, Yanada S, Ishikawa M, Adachi N, Deie M, Arihiro K. A novel cell delivery system using magnetically labeled mesenchymal stem cells and an external magnetic device for clinical cartilage repair. Arthroscopy. 2008;24:69\u201376.","journal-title":"Arthroscopy"},{"key":"3726_CR94","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1089\/ten.tea.2017.0235","volume":"24","author":"TD Bornes","year":"2018","unstructured":"Bornes TD, Adesida AB, Jomha NM. Articular cartilage repair with mesenchymal stem cells after chondrogenic priming: a pilot study. Tissue Eng Part A. 2018;24:761\u201374.","journal-title":"Tissue Eng Part A"},{"key":"3726_CR95","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1007\/s00167-018-4898-2","volume":"26","author":"N Kamei","year":"2018","unstructured":"Kamei N, Ochi M, Adachi N, Ishikawa M, Yanada S, Levin LS, Kamei G, Kobayashi T. The safety and efficacy of magnetic targeting using autologous mesenchymal stem cells for cartilage repair. Knee Surg Sports Traumatol Arthrosc. 2018;26:3626\u201335.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"3726_CR96","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3892\/etm.2015.2944","volume":"11","author":"Y Qi","year":"2016","unstructured":"Qi Y, Yang Z, Ding Q, Zhao T, Huang Z, Feng G. Targeted transplantation of iron oxide-labeled, adipose-derived mesenchymal stem cells in promoting meniscus regeneration following a rabbit massive meniscal defect. Exp Ther Med. 2016;11:458\u201366.","journal-title":"Exp Ther Med"},{"issue":"38","key":"3726_CR97","doi-asserted-by":"crossref","first-page":"eaay6626","DOI":"10.1126\/scirobotics.aay6626","volume":"5","author":"J Li","year":"2020","unstructured":"Go G, Jeong S G, Yoo A, Han J, Kang B, Kim S, Nguyen KT, Jin Z, Kim CS, Seo YR, Kang J Y, Na JY, Song EK, Jeong Y, Seon JK, Park JO, Choi E. Human adipose-derived mesenchymal stem cell-based medical microrobot system for knee cartilage regeneration in vivo. Sci Robot. 2020;5(38):eaay6626.","journal-title":"Sci Robot"},{"key":"3726_CR98","doi-asserted-by":"publisher","first-page":"eaat8829","DOI":"10.1126\/scirobotics.aat8829","volume":"3","author":"J Li","year":"2018","unstructured":"Li J, Li X, Luo T, Wang R, Liu C, Chen S, Li D, Yue J, Cheng SH, Sun D. Development of a magnetic microrobot for carrying and delivering targeted cells. Sci Robot. 2018;3:eaat8829.","journal-title":"Sci Robot"},{"key":"3726_CR99","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11596-011-0253-2","volume":"31","author":"Y Feng","year":"2011","unstructured":"Feng Y, Jin X, Dai G, Liu J, Chen J, Yang L. In vitro targeted magnetic delivery and tracking of superparamagnetic iron oxide particles labeled stem cells for articular cartilage defect repair. J Huazhong Univ Sci Technolog Med Sci. 2011;31:204\u20139.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"3726_CR100","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3727\/096368915X689613","volume":"25","author":"EE Mahmoud","year":"2016","unstructured":"Mahmoud EE, Kamei G, Harada Y, Shimizu R, Kamei N, Adachi N, Misk NA, Ochi M. Cell magnetic targeting system for repair of severe chronic osteochondral defect in a rabbit model. Cell Transplant. 2016;25:1073\u201383.","journal-title":"Cell Transplant"},{"key":"3726_CR101","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00776-014-0548-9","volume":"19","author":"S Oshima","year":"2014","unstructured":"Oshima S, Kamei N, Nakasa T, Yasunaga Y, Ochi M. Enhancement of muscle repair using human mesenchymal stem cells with a magnetic targeting system in a subchronic muscle injury model. J Orthop Sci. 2014;19:478\u201388.","journal-title":"J Orthop Sci"},{"key":"3726_CR102","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1302\/0301-620X.94B7.28521","volume":"94","author":"A Kodama","year":"2012","unstructured":"Kodama A, Kamei N, Kamei G, Kongcharoensombat W, Ohkawa S, Nakabayashi A, Ochi M. In vivo bioluminescence imaging of transplanted bone marrow mesenchymal stromal cells using a magnetic delivery system in a rat fracture model. J Bone Joint Surg Br. 2012;94:998\u20131006.","journal-title":"J Bone Joint Surg Br"},{"key":"3726_CR103","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1177\/0363546513483270","volume":"41","author":"G Kamei","year":"2013","unstructured":"Kamei G, Kobayashi T, Ohkawa S, Kongcharoensombat W, Adachi N, Takazawa K, Shibuya H, Deie M, Hattori K, Goldberg JL, Ochi M. Articular cartilage repair with magnetic mesenchymal stem cells. Am J Sports Med. 2013;41:1255\u201364.","journal-title":"Am J Sports Med"},{"key":"3726_CR104","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/RLI.0b013e3181ed566c","volume":"45","author":"A Nedopil","year":"2010","unstructured":"Nedopil A, Klenk C, Kim C, Liu S, Wendland M, Golovko D, Schuster T, Sennino B, McDonald DM, Daldrup-Link HE. MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis. Invest Radiol. 2010;45:634\u201340.","journal-title":"Invest Radiol"},{"key":"3726_CR105","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.arthro.2009.06.009","volume":"25","author":"T Kobayashi","year":"2009","unstructured":"Kobayashi T, Ochi M, Yanada S, Ishikawa M, Adachi N, Deie M, Arihiro K. Augmentation of degenerated human cartilage in vitro using magnetically labeled mesenchymal stem cells and an external magnetic device. Arthroscopy. 2009;25:1435\u201341.","journal-title":"Arthroscopy"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03726-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T08:02:56Z","timestamp":1701331376000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03726-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3726"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03726-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors consented to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare that there is no conflict of interests regarding the publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"515"}}